It's quite easy to be negative about this company
Post# of 30028
Posted On: 03/07/2016 10:25:47 AM
It's quite easy to be negative about this company after the hype the CEO has pumped.
Most longs are down 90% plus and we are trading at .12 after a 150 to 1 RS from strength.
The best partnership we can muster is with a otc company and now we are footing a 400k bill for another member of this merger, when we are supposedly using what little money we have left to focus on ESS.
Most will actually be happy when one of the supposed scientific advancements take place. If they actually finish a trial to move ESS forward is a huge step for the company.
However the track record speaks for itself. Point in case CLIA for the diagnostics or the ELTO trials that was postponed.
I'm just curious that others are posting about 40k dollars spent to pump this stock the same day a press release is issued. Either somebody has inside info or one of the companies involved is paying for it.
WD
Most longs are down 90% plus and we are trading at .12 after a 150 to 1 RS from strength.
The best partnership we can muster is with a otc company and now we are footing a 400k bill for another member of this merger, when we are supposedly using what little money we have left to focus on ESS.
Most will actually be happy when one of the supposed scientific advancements take place. If they actually finish a trial to move ESS forward is a huge step for the company.
However the track record speaks for itself. Point in case CLIA for the diagnostics or the ELTO trials that was postponed.
I'm just curious that others are posting about 40k dollars spent to pump this stock the same day a press release is issued. Either somebody has inside info or one of the companies involved is paying for it.
WD
(5)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼